Live News Categoriesequity

Nxera Pharma Co., Ltd. (4565.T) News

Follow Nxera Pharma Co., Ltd. (4565.T) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 4565.T Asset equity Sector Markets 90 days 1 Last 1,183 Updated Oct 14, 2026, 07:05 AM UTC Open live news feed

L BRIEF — Nxera Pharma — Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia — Pacific Markets Oct 14 (Reuters) — Nxera Pharma Co., Ltd.: Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-pacific Markets Source text:... Further company coverage: 4565. NEWS | Oct 14, 2026, 07:05 AM UTC